With the analysis among 200 patents, we discovered top 35 key players by total patent application. Ambrx, Inc., PSMA Development Co. LLC, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) are dominant in this area. They take 43.50% of the total patent filing.
California, United States
Patent: 37
New York, United States
Patent: 35
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 14
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 13
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 13
Sorrento Therapeutics, Inc.
California, United States
Patent: 12
Cambridgeshire, United Kingdom
Patent: 8
California, United States
Patent: 8
Vaud, Switzerland
Patent: 6
No data, please try another search term
With the analysis among related 68 patents applied in the last 5 years. We discover 24 most active companies in this area. The fast-growing Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Ambrx, Inc. take 54.41% of patent filing during this period.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 13
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 13
California, United States
Patent: 11
Telix International Pty Ltd
undefined undefined
Patent: 10
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 5
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 4
Cambridgeshire, United Kingdom
Patent: 3
Nantong Yichen Biomedical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Vaud, Switzerland
Patent: 3
With the analysis among related 68 patents in last 5 years, we discover 16 new entrants. Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Telix International Pty Ltd are the most active new entrants in this area.
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 13
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 13
Telix International Pty Ltd
undefined undefined
Patent: 10
Nantong Yichen Biomedical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
CytomX Therapeutics, Inc.
California, United States
Patent: 2
California, United States
Patent: 2
California, United States
Patent: 2
Shanghai Yichen Pharmaceutical Technology Co., Ltd.
Shanghai Shi, China
Patent: 1
Technische Universität München
With the analysis among 23 patents, we discovered top 4 universities and scientific research institutions by total patent application. Eberhard Karls Universität Tübingen, Cornell University, University College London are dominant in this area. They take 147.83% of the total patent filing.
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 14
New York, United States
Patent: 5
University College London
Technische Universität München